Effect of Musical Auditory Training on Subjects With Tinnitus Disorder
Launched by UNIVERSIDADE FEDERAL DE SANTA MARIA · Apr 15, 2024
Trial Information
Current as of September 11, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a special type of training called Musical Auditory Training (MAT) on individuals who experience tinnitus, a condition characterized by hearing ringing or buzzing sounds that aren't there. The goal is to see if engaging in musical activities can help change the way the brain processes sound, potentially improving the experience of tinnitus for young adults aged 18 to 55 who have been living with this condition for at least six months.
To participate in this trial, individuals must have normal hearing or mild hearing loss and must find their tinnitus bothersome enough to rate it as a moderate discomfort. Participants will not be eligible if they have certain neurological or psychiatric issues, have experienced recent head trauma, or are currently undergoing other treatments for tinnitus. Those who join can expect to engage in various musical exercises aimed at helping their brain adapt and possibly reduce the annoyance caused by tinnitus. This study is currently recruiting participants, and it's an exciting opportunity for those looking to explore new ways to manage their tinnitus.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals of both sexes aged between 18 years and 55 years;
- • Complaint of chronic tinnitus (minimum perception of six months) unilateral or bilateral;
- • Hearing thresholds within normal limits bilaterally or even mild sensorineural hearing loss in the four-tone average (500, 1000, 2000 and 4000Hz);
- • Annoyance score of at least four on the Visual Analogue Scale, considered a moderate symptom discomfort;
- • Have normality in the Mini Mental State Examination (cognitive screening).
- Exclusion Criteria:
- • Apparent speech, psychiatric or neurological changes;
- • History of head or brain trauma;
- • Objective tinnitus (somatosensory and vascular);
- • Present symptoms and/or diagnosis of middle ear involvement;
- • Having started a new treatment (pharmacological or therapeutic) or having been diagnosed with a disease of any origin in the last month.
- • Be carrying out another intervention for tinnitus during the research;
- • Use of electronic assistive hearing devices.
About Universidade Federal De Santa Maria
The Universidade Federal de Santa Maria (UFSM) is a prominent Brazilian academic institution known for its commitment to advancing research and education in the health sciences. As a clinical trial sponsor, UFSM leverages its extensive resources and expertise to conduct innovative studies aimed at improving patient outcomes and contributing to the scientific community. The university fosters a collaborative environment, engaging multidisciplinary teams of researchers, healthcare professionals, and students to ensure rigorous methodology and adherence to ethical standards in clinical research. Through its focus on cutting-edge medical research, UFSM plays a vital role in addressing health challenges and enhancing the quality of care in Brazil and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Santa Maria, Rs, Brazil
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported